Search This Blog

Thursday, June 11, 2020

FDA OKs Pfizer’s Neulasta biosimilar

The FDA approves Pfizer’s (NYSE:PFE) Nyvepria (pegfilgrastim-apgf), a bisimilar to Amgen’s (NASDAQ:AMGN) Neulasta, its sixth biosimilar approved in the U.S.
https://seekingalpha.com/news/3582254-fda-oks-pfizers-neulasta-biosimilar
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)